Protección jurídica de las invenciones biotecnológicas en el marco de la Unión Europea: sentencia del 6 de julio de 2010 del Tribunal de Justicia de la Unión Europea

In view of new developments in genetic engineering and in the context of a globalized economy, in which what sacrifices one, is won by the other, the law assumes a role of settling and balancing these overlapped interests. This article aims to present a concrete analysis of the European Court of Jus... Deskribapen osoa

Egile nagusia: Herrera Sierra, Luisa Fernanda
Formatua: Artikulua
Hizkuntza: Gaztelania
Argitaratua: Universidad Externado de Colombia 2011
Gaiak:
44
ec
44
EC
Sarrera elektronikoa: http://dialnet.unirioja.es/servlet/oaiart?codigo=3785216
Etiketak: Erantsi etiketa bat
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Azalaren irudirik gabe QR Kodea
Gorde:
Laburpena: In view of new developments in genetic engineering and in the context of a globalized economy, in which what sacrifices one, is won by the other, the law assumes a role of settling and balancing these overlapped interests. This article aims to present a concrete analysis of the European Court of Justice Decision of July 6, 2010, that established the spatial and temporal application of the Article 9 of the European Directive 98/44/ec. This rule determines that the protection conferred by a patent for a dna sequence, integrated with other products, depends on the exercise of the function for which it was patented. A decision in this direction has a major influence on innovation impulse by allowing the appearance of new scenarios caused by different uses of the protected sequences. The rights of big knowledge innovators such as Monsanto, must be surrounded by a clear legal framework concerning the extension of the protection conferred; otherwise, the commercialization, development and creation of new products would be limited in excess.